3.73 (-%)
As of Nov 20, 2024
Source:
Our mission is to transform ophthalmology and optometry through the development and commercialization of proprietary devices that target the underlying causes of the worlds most prevalent eye diseases. We are passionate about improving patients lives. Our business philosophy is grounded in the following principles: comprehensively understanding disease physiology; developing products that are intended to restore natural physiological functionality to diseased eyes; developing and marketing products that achieve superior effectiveness versus current treatment paradigms while minimizing complications or side effects; providing intuitive, patient friendly solutions to ophthalmologists and optometrists (together, eyecare professionals or ECPs); and delivering compelling economic value to all stakeholders, including patients, providers and third- party payors such as Medicare and commercial insurers. Our objective is to develop and market products for use in new treatment paradigms and to create an interventional mindset in eyecare whereby our products may be used in procedures which supplant conventional outdated approaches. We believe current eyecare treatment models rely heavily on prescription medications, symptom relief, or either flawed or highly invasive, later-stage procedural interventions, and often fail to adequately address the true underlying cause of disease.
Country | United States |
Headquarters | menlo park, california |
Phone Number | (415) 889-0550 |
Industry | |
CEO | Paul Badawi |
Website | www.sightsciences.com |